Search research articles
Contact Us
Filters
Showing results (381-390 of 520) with videos related to
Page
of 52
Sort By:
Blood
|
September 25, 2024
Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma
Holly Lee, Michael Durante, Sheri Skerget, et al.
Blood Cancer Journal
|
May 31, 2022
Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
Cody Ashby, Eileen M Boyle, Michael A Bauer, et al.
Leukemia Research
|
January 28, 2014
Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases
Prashant R Tembhare, Constance M Yuan, David Venzon, et al.
Nature Communications
|
August 3, 2022
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
Leo Rasche, Carolina Schinke, Francesco Maura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma
Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, et al.
Blood Advances
|
November 4, 2022
Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations
Kylee H Maclachlan, Tina Bagratuni, Efstathios Kastritis, et al.
Cancer Immunology Research
|
May 23, 2019
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy
Eric L Smith, Sham Mailankody, Mette Staehr, et al.
Blood
|
April 27, 2022
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma
Michael D Jain, Bachisio Ziccheddu, Caroline A Coughlin, et al.
NPJ Precision Oncology
|
October 19, 2022
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)
Nina Nguyen, Sana Chaudhry, Tulasigeri M Totiger, et al.
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
The Vk*MYC Mouse Model recapitulates human multiple myeloma evolution and genomic diversity
Francesco Maura, David G Coffey, Caleb K Stein, et al.
Page
of 52
Search research articles
Search
Showing results (381-390 of 520) with videos related to
Sort By:
Page
of 52
Blood
|
September 25, 2024
Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma
Holly Lee, Michael Durante, Sheri Skerget, et al.
Blood Cancer Journal
|
May 31, 2022
Structural variants shape the genomic landscape and clinical outcome of multiple myeloma
Cody Ashby, Eileen M Boyle, Michael A Bauer, et al.
Leukemia Research
|
January 28, 2014
Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases
Prashant R Tembhare, Constance M Yuan, David Venzon, et al.
Nature Communications
|
August 3, 2022
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
Leo Rasche, Carolina Schinke, Francesco Maura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma
Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou, et al.
Blood Advances
|
November 4, 2022
Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations
Kylee H Maclachlan, Tina Bagratuni, Efstathios Kastritis, et al.
Cancer Immunology Research
|
May 23, 2019
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy
Eric L Smith, Sham Mailankody, Mette Staehr, et al.
Blood
|
April 27, 2022
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma
Michael D Jain, Bachisio Ziccheddu, Caroline A Coughlin, et al.
NPJ Precision Oncology
|
October 19, 2022
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)
Nina Nguyen, Sana Chaudhry, Tulasigeri M Totiger, et al.
Biorxiv : the Preprint Server for Biology
|
August 7, 2023
The Vk*MYC Mouse Model recapitulates human multiple myeloma evolution and genomic diversity
Francesco Maura, David G Coffey, Caleb K Stein, et al.
Page
of 52